Cited by 1,025Cancer Cells and MetastasisGlioma Diagnosis and TreatmentNeurogenesis and neuroplasticity mechanisms

Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens

Open access
Pollard, Steven M., Yoshikawa, Koichi, Clarke, Ian D., Danovi, Davide, Stricker, Stefan, Russell, Roslin, Bayani, Jane, Head, Renee +5 more·2009·Cell Stem Cell

Abstract

Human brain tumors appear to have a hierarchical cellular organization suggestive of a stem cell foundation. In vitro expansion of the putative cancer stem cells as stable cell lines would provide a powerful model system to study their biology. Here, we demonstrate routine and efficient derivation of adherent cell lines from malignant glioma that display stem cell properties and initiate high-grade gliomas following xenotransplantation. Significantly, glioma neural stem (GNS) cell lines from different tumors exhibit divergent gene expression signatures and differentiation behavior that correlate with specific neural progenitor subtypes. The diversity of gliomas may, therefore, reflect distinct cancer stem cell phenotypes. The purity and stability of adherent GNS cell lines offer significant advantages compared to "sphere" cultures, enabling refined studies of cancer stem cell behavior. A proof-of-principle live cell imaging-based chemical screen (450 FDA-approved drugs) identifies both differential sensitivities of GNS cells and a common susceptibility to perturbation of serotonin signaling.

Integrity signals

Registry

Crossref · 10.1016/j.stem.2009.03.014

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Pollard, S. M., Yoshikawa, K., Clarke, I. D., Danovi, D., Stricker, S., Russell, R., Bayani, J., Head, R., Lee, M., Bernstein, M., Squire, J. A., Smith, A., & Dirks, P.
Affiliations
  • Wellcome/MRC Cambridge Stem Cell Institute (GB)
  • University of Toronto (CA)
  • University Health Network (CA)
  • Western General Hospital (GB)
  • Queen's University (CA)
Corresponding author
  • Pollard, Steven M.
  • Dirks, Peter
Venue
Cell Stem Cell
Publisher
Elsevier BV
Published
2009-06
Volume
4
Issue
6
Pages
568-580
ISSN
  • 1875-9777 (ISSN-L)
  • 1934-5909
OpenAlex
W2081758137
Cited by
1,025
References
48
Citations by year
2026: 23 · 2025: 34 · 2024: 41 · 2023: 56 · 2022: 60 · 2021: 82 · 2020: 66 · 2019: 59 · 2018: 69 · 2017: 74 · 2016: 68 · 2015: 66 · 2014: 62 · 2013: 66 · 2012: 69
FWCI
32.78
Type
journal article
Language
en
Open access
Locations
  • Cell stem cell (publishedVersion)
  • PubMed (publishedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
  • UCL Discovery (University College London) (submittedVersion)
Funders
  • Genome Canada
  • Ontario Genomics
  • Ontario Genomics Institute
  • Stem Cell Network
  • Cancer Research UK
  • University of Toronto
  • Hospital for Sick Children
  • Directorate for Biological Sciences
  • Medical Research Council
  • Biotechnology and Biological Sciences Research Council
  • Christ's College, University of Cambridge
  • National Cancer Institute
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
Keywords
glioma, cancer stem cells, adherent culture, neural stem cells, tumor heterogeneity, xenotransplantation, gene expression signatures, chemical screen, drug sensitivity, serotonin signaling, high-grade glioma
MeSH terms
Animals, Cell Adhesion, Drug Screening Assays, Antitumor, Glioma, Humans, Serotonin, Transplantation, Heterologous, Neoplastic Stem Cells, Mice, SCID, Gene Expression Profiling, Cell Line, Tumor, Culture Techniques, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review